June 9th, 2009Sirona Biochem Appoints A Leading Biotech Scientist To Progress Its Diabetes And Obesity Drug Discovery Program
May 18th, 2009Sirona Biochem Corp. (TSX-V: SBM) Attends BIO International, Worlds Largest Biotech Convention
May 1st, 2009Canada’s First Public Biotech Company since 2007 is launched to help combat the “twin epidemics” – Diabetes and Obesity.
April 29th, 2009Sirona Biochem Corp. Management Team Restructuring: Mark Senner appointed to President, Christopher Hopton to Chief Financial Officer and John Dougherty to Corporate Development
